Skip to content
Screener

McKesson MCK Price / sales

Price / sales at other companies

Eli Lilly logo
Eli LillyLLY
11.4×-3.8×
Cardinal Health logo
Cardinal HealthCAH
0.2×0.0×
Cencora logo
CencoraCOR
0.2×0.0×
AbbVie logo
AbbVieABBV
6.9×+1.3×
Amneal Pharmaceuticals, Inc. logo
Amneal Pharmaceuticals, Inc.AMRX
1.3×+0.4×
Viatris logo
ViatrisVTRS
1.1×+0.3×

Other financials

Income statement

See full
Revenue$96.3B+6.0%
Gross profit$4.0B+11.1%
Operating income$2.2B+35.1%
Net income$1.7B+33.5%
EPS (diluted)$13.65+37.6%

Balance sheet

See full
Cash & equivalents$4.0B-33.3%
Total debt$2.3B-74.2%
Total equity-$2.2B-4.7%
Total assets$82.3B+9.6%

Cash flow

See full
Operating cash flow$3.4B-55.8%
CapEx$111.0M-34.3%
Free cash flow$3.3B-56.3%

Valuation

See full
Market cap$100.24B+12.9%
Enterprise value$98.54B+1.3%
P/E21.1×-7.0×

Profitability

See full
Gross margin3.6%-0.1pp
Operating margin1.5%+0.3pp
Net margin1.2%+0.3pp
FCF margin1.4%-0.1pp

Returns & leverage

See full
Return on equity36%
Debt / equity
Current ratio0.9×0.0×

Where this comes from

Calculated from McKesson’s reported figures.

Based on the most recent quarter.

The source filing: McKesson’s 10-K, filed May 8, 2026. Open the filing →

Filed
May 7, 2026, 8:00 PM EDT
Fiscal year
FY2026
Accession
0000927653-26-000069

FAQ

What is McKesson's price / sales?
McKesson (MCK) reported price / sales of 0.3× in Q1 2026.
How has McKesson's price / sales changed year-over-year?
McKesson's price / sales increased by 11.8% year-over-year, from 0.2× to 0.3×.
What is the long-term trend for McKesson's price / sales?
Over 5 years (2021 to 2026), McKesson's price / sales has grown at a 16.0% compound annual growth rate (CAGR), from 0.1× to 0.3×.
What does price / sales mean?
Market capitalization at the quarter end divided by trailing-twelve-month revenue. The price the market pays for each dollar of sales.

Ask your AI about McKesson's price / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude